Search clinical trials for: Paclitaxel injection

Total 13563 results

City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic Carcinoma

United States
Mayo Clinic
National Cancer Institute (NCI)

Withdrawn

Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
City of Hope Medical Center
National Cancer Institute (NCI); National Comprehensive Cancer Network

Completed

Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Ovarian Cancer | Peritoneal Cavity Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
Chinese PLA General Hospital

Unknown

An Open-label, Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic Pancreatic Cancer

Pancreatic Cancer

China
China Medical University, China

Unknown

S1+ Paclitaxel (IV&IP) + Bevacizumab (IP) Versus S1+Oxaliplatin as First-line Treatment in Gastric Cancer With Malignant Ascites

Metastatic Gastric Adenocarcinoma

China
Hunan Cancer Hospital

Recruiting

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Ovarian Cancer

China
University of Texas Southwestern Medical Center
Celgene

Completed

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER

United States
CARsgen Therapeutics Co., Ltd.
Fudan University; Peking University Cancer Hospital & Institute

Recruiting

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Pancreatic Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma

China
AstraZeneca

Recruiting

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

Gastric Cancer | Gastroesophageal Junction Cancer

Canada, Spain, United Kingdom, China, France, Italy, Vietnam, Germany, United States, India, Taiwan, Thailand, Hong Kong, Japan, Switzerland, Poland
Chengdu Kanghong Biotech Co., Ltd.

Unknown

Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy

Gastric Cancer | Gastroesophageal Cancer
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Recurrent Ovarian Carcinoma | Primary Peritoneal Carcinoma

United States
Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Severe Asthma

China
University of Ulm
B. Braun Melsungen AG

Completed

The Paclitaxel-Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) - Balloon Catheter in Coronary Artery Disease to Treat Chronic Total Occlusions (PEPCAD-CTO)

Coronary Artery Disease | Chronic Total Occlusion | Native Coronary Artery

Germany
Emory University
National Cancer Institute (NCI)

Active, not recruiting

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Advanced Pancreatic Adenocarcinoma

United States
Jilin University

Not yet recruiting

Paclitaxel Injection (Albumin-bound) for Neoadjuvant Treatment of Breast Cancer

Breast Cancer Stage

China
Tata Memorial Hospital

Active, not recruiting

A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer

India
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

Overweight or Obesity
Mayo Clinic

Recruiting

Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy

Facet-Mediated Low Back Pain

United States
Beijing Anzhen Hospital

Recruiting

Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury (RESTORE)

Myocardial Infarction

China
Centre Hospitalier Universitaire Vaudois

Completed

Distant Extrafascial Injection vs Subfascial Injection for Interscalene Block: Acute Pain Outcomes and Rates of Complications

Shoulder Surgery | Postoperative Analgesia | Respiratory Function | Interscalene Block | Ultrasound-guided Regional Anesthesia

Switzerland
King's College London
Guy's and St Thomas' NHS Foundation Trust

Completed

Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De) (MultiPepT1De)

Type 1 Diabetes

United Kingdom
Akeso

Recruiting

A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer

Metastatic Triple-negative Breast Cancer | Locally Advanced Triple-negative Breast Cancer

China
Hutchison Medipharma Limited

Completed

A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer

Gastric Cancer

China
McMaster University
HAMSMaRT; Keeping Six; YWCA Hamilton

Not yet recruiting

The Injection-Related InfectionS (IRIS) Program (IRIS)

Infections | Peer Support | Injection-related Infections | People Who Infect Drugs (PWID)

Canada
Immorna Biotherapeutics, Inc.

Recruiting

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Malignant Solid Tumor | Cutaneous Tumor

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

Asthma | Atopic Dermatitis | COPD

China
Mabwell (Shanghai) Bioscience Co., Ltd.
Huashan Hospital

Completed

A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

Staphylococcus Aureus Infection

China
Gmax Biopharm Australia Pty Ltd.
Metaclinical; Syneos Heath

Completed

A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers

Pulmonary Arterial Hypertension

Australia
Vivozon, Inc.

Completed

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

Healthy
Fudan University

Active, not recruiting

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC. (FUTURE-SUPER)

TNBC - Triple-Negative Breast Cancer

China
Sichuan Provincial People's Hospital

Unknown

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

HER2-negative Breast Cancer

China
M.D. Anderson Cancer Center
Celgene

Completed

Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas

Colorectal Cancer | Cancer of Gastrointestinal Tract

United States
Ospedale San Donato

Terminated

A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR) (COMPACT-ISR)

Stable Angina | Unstable Angina

Italy
Beijing Tiantan Hospital

Not yet recruiting

Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis (SPECIALS)

Amyotrophic Lateral Sclerosis

China
Huashan Hospital

Not yet recruiting

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Pompe Disease (Late-onset)

China
NYU Langone Health

Recruiting

UB-312 in Patients With Synucleinopathies

Parkinson Disease | Multiple System Atrophy

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes

China
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Overweight or Obesity

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Beijing Zheng Ju Medical Technology Co., Ltd.

Unknown

The Randomized Controlled Clinical Trial of Kushen Injection

Lung Cancer

China
Zhejiang Kanglaite Pharmaceutical Co.Ltd
H & J CRO International, Inc.

Unknown

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Cancer Cachexia

China
Chinese PLA General Hospital

Unknown

A Phase I/II Study of the Pan-immunotherapy in Patients With Local Advanced/Metastatic BTC

Biliary Tract Cancer (BTC)

China
Vivozon, Inc.

Completed

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (P1_VVZ149IV)

Healthy

Korea, Republic of
Vascular Biogenics Ltd. operating as VBL Therapeutics
GOG Foundation

Completed

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) (OVAL)

Recurrent Platinum Resistant Ovarian Cancer

United States, Israel, Japan, Poland, Spain
Junling Li

Unknown

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Extensive-Stage Small Cell Lung Cancer

China
Tao OUYANG

Completed

Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer

Breast Cancer

China
Zhejiang University

Unknown

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer

Non Small Cell Lung Cancer

China
AstraZeneca

Completed

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients (BEECH)

Advanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast Cancer

Canada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
Onxeo
Spectrum Pharmaceuticals, Inc

Completed

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Carcinoma of Unknown Primary

United States, Germany, France, Denmark

Search clinical trials for: Paclitaxel injection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations